| 221 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy/
|
Rawstron, A C
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 222 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Raised blast glutathione levels are associated with an increased risk of relapse in childhood acute lymphocytic leukemia/
|
Kearns, R R
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 223 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients - for the French Cooperative Group on Chronic Lymphocytic Leukemia/
|
Leporrier, M
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 224 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation/
|
Narayanasami, U
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 225 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b/
|
Calderwood, S
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 226 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Regulation of monocyte procoagulant activity in acute myocardial infarction: Role of tissue factor and tissue factor pathway inhibitor-1/
|
Ott, I
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 227 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Relationship between transferrin saturation and iron stores in the African American and US Caucasian populations: Analysis of data from the third National Health and Nutrition Examination Survey/
|
McLaren, C E
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 228 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute myeloid leukemia/
|
Webb, D K H
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 229 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: Risk factors, correlation with DNA load, and outcomes/
|
Nichols, W G
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 230 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors/
|
Nowak-G�ttl, U
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 231 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: Clinical and molecular evaluation/
|
Colombat, P
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 232 |
|
CLINICAL OBSERVATIONS INTERVENTIONS, AND THERAPEUTIC TRIALS - Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura/
|
Stasi, R
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 233 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Rituximab therapy of patients with B-cell chronic lymphocytic leukemia/
|
Huhn, D
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 234 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: A prospective validation/
|
Maertens, J
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 235 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection/
|
Sidenius, N
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 236 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Serum mn23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma/
|
Niitsu, N
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 237 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: A report of the Berlin-Frankfurt-M�nster Group Trial NHL-BFM 90/
|
Seidemann, K
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 238 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: A study of 111 cases/
|
Veyradier, A
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 239 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies/
|
Sanz, G F
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 240 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide/
|
Westervelt, P
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
기사
(465)
